GoldBamboo.com - Knowledge is strong medicine
  

Evaluation of Abstinence-Only and Abstinence-Plus Programs to Prevent HIV, STD, and Pregnancy Among Middle School Students - Article


  Not Signed In - Sign In / Register






Abstinence


Clinical Trial: Evaluation of Abstinence-Only and Abstinence-Plus Programs to Prevent HIV, STD, and Pregnancy Among Middle School Students

This study is not yet open for patient recruitment.
Verified by Centers for Disease Control and Prevention September 2005

Sponsored by: Centers for Disease Control and Prevention
Information provided by: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00207545

Purpose

Researchers are evaluating the effectiveness of a risk avoidance curriculum (a Title V compliant education curriculum teaching skills for abstaining from sexual intercourse until marriage) and a risk reduction curriculum (a curriculum teaching skills for sexual abstinence and condom and contraceptive use) in reducing sexual behaviors that may lead to HIV infection, sexually transmitted diseases, and pregnancy among students at 15 inner-city middle schools in Texas. Each of five schools is being randomly assigned to the risk avoidance curriculum, the risk reduction curriculum, or the normal care comparison group. About 1,500 seventh-grade students are being recruited from the schools for this two-year program. Both programs consist of a classroom curriculum and a CD-ROM for use with both seventh and eighth grade students. Both programs, conducted by trained facilitators, include in-class group activities to address attitudes, skills, self-efficacy, and norms related to dating and sexual risk-taking behavior. The CD-ROM component includes activities that tailor information and skills to the student’s current behavior or intentions regarding sex. The risk avoidance curriculum emphasizes abstinence until marriage and does not address skills to reduce sexual risk behaviors or skills to access services to obtain contraceptives or services to prevent HIV, sexually transmitted infections, or pregnancy, which are discussed in the risk reduction curriculum. Community input is helping to ensure both programs are responsive to local needs and concerns. The study will determine whether the students’ sexual risk-taking behaviors differ by the type of program in which they were involved by comparing each to the comparison group.
Condition Intervention Phase
HIV
Sexually Transmitted Diseases
Pregnancy
 Behavior: Sexual risk avoidance intervention
 Behavior: Sexual risk reduction intervention
 Behavior: Usual care school-based sexual eduction
Phase II

MedlinePlus related topics:  Sexually Transmitted Diseases

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Further Study Details: 
Primary Outcomes: Sexual behavior, including abstinence from oral, anal, and vaginal intercourse; reduction of sexual partners; use of condoms and contraception.
Secondary Outcomes: Secondary hypotheses will examine the effect of the Students’ knowledge, self-efficacy, refusal skills, attitudes,
Expected Total Enrollment:  2000

Study start: October 2005;  Expected completion: September 2009
Last follow-up: July 2009;  Data entry closure: July 2009

Eligibility

Ages Eligible for Study:  10 Years   -   16 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • For Phase I, approximately 80 7th and 8th grade students will be recruited from regular classes in HISD middle schools (e.g. Health Education, Physical Education, English, or Science) to participate in focus groups. During recruitment, students will be informed that focus groups will be conducted in English. Students will be asked to consider their level of comfort with participating in an English-only focus group prior to agreeing to participate. Approximately 80 parents of 7th and 8th grade students will also be recruited from schools and community organizations to participate in focus groups. Additionally, approximately 12-15 HISD personnel will be contacted through previously identified school contacts and invited to participate in interviews.

For Phase II, 7th and 8th grade students will be recruited from regular classes in 4-6 HISD middle schools to participate in pilot testing of the survey and intervention. Students will be informed that the survey and intervention materials will only be pilot tested in English and asked to consider their comfort level with participating in an English-only pilot test prior to agreeing to participate.

For Phase III, HISD middle schools serving predominantly minority youth will be invited to participate in the main evaluation study. Of these, 15 schools will be randomized to intervention and comparison conditions. Approximately 1500 7th grade students will be recruited into the study with approximately equal representation of male and female students. Students will be recruited through regular classes until the minimum sample size is obtained (approximately 100 students per school). Students will be informed that the surveys and intervention materials will only be available in English and asked to consider their comfort level with participating in the study.

Exclusion Criteria:

  • No students in the 7th and 8th grade will be excluded based on race/ethnicity, age, or gender. For all phases of the study, individuals of other race/ethnicities (e.g. Non-Hispanic Whites, Asian, and Native American) that express interest and/or agree to participate will not be excluded. For all Phases, students will be recruited from regular classes in HISD middle schools (e.g. Health Education, Physical Education, English, or Science). Students will be informed that the surveys and intervention materials will only be available in English and will be asked to consider their comfort level with participating in the study. However, we anticipate that the majority of students will be fluent in English and able to participate in the study. For Phase I, both mothers and fathers whose 7th and 8th graders live with them most of the time will be recruited to participate in the parent focus groups. However, we anticipate that the majority of these participants will be mothers.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00207545

Christine Markham, PhD      (713) 500-9646    Christine.Markham@uth.tmc.edu

Texas
      Center for Health Promotion and Prevention Research, University of Texas, Houston, Houston,  Texas,  77030,  United States
Christine Markham, PhD  713-500-9646    Christine.Markham@uth.tmc.edu 
Christine Markham, PhD,  Principal Investigator

Study chairs or principal investigators

Leah E Robin, PhD,  Study Chair,  Centers for Disease Control and Prevention   
Christine Markham, PhD,  Principal Investigator,  University of Texas, Houston   

More Information

Study ID Numbers:  CDC-NCCDPHP-4586; CPHS HSC-SPH-04-094
Last Updated:  September 20, 2005
Record first received:  September 13, 2005
ClinicalTrials.gov Identifier:  NCT00207545
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-27


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Abstinence.

August 28, 2008



Page Updated: September 6, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.